ATE347545T1 - Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren - Google Patents

Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren

Info

Publication number
ATE347545T1
ATE347545T1 AT00959170T AT00959170T ATE347545T1 AT E347545 T1 ATE347545 T1 AT E347545T1 AT 00959170 T AT00959170 T AT 00959170T AT 00959170 T AT00959170 T AT 00959170T AT E347545 T1 ATE347545 T1 AT E347545T1
Authority
AT
Austria
Prior art keywords
indole derivatives
spla2 inhibitors
derivatives active
hydroxyfunctional amide
hydroxyfunctional
Prior art date
Application number
AT00959170T
Other languages
English (en)
Inventor
Richard Waltz Harper
Ho-Shen Lin
Michael Enrico Richett
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE347545T1 publication Critical patent/ATE347545T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
AT00959170T 1999-09-20 2000-09-07 Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren ATE347545T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15483699P 1999-09-20 1999-09-20

Publications (1)

Publication Number Publication Date
ATE347545T1 true ATE347545T1 (de) 2006-12-15

Family

ID=22553008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00959170T ATE347545T1 (de) 1999-09-20 2000-09-07 Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren

Country Status (6)

Country Link
EP (1) EP1220839B1 (de)
JP (1) JP2003509491A (de)
AT (1) ATE347545T1 (de)
AU (1) AU7053700A (de)
DE (1) DE60032254D1 (de)
WO (1) WO2001021587A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930123B2 (en) 2000-12-18 2005-08-16 Eli Lilly And Company sPLA2 inhibitors
ATE353876T1 (de) * 2001-03-28 2007-03-15 Lilly Co Eli Substituierte carbazole als inhibitoren von spla2
US20090306171A1 (en) * 2005-11-03 2009-12-10 Han-Ting Chang Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors
JP2009514893A (ja) 2005-11-03 2009-04-09 イリプサ， インコーポレイテッド 多価インドール化合物およびホスホリパーゼａ２インヒビターとしてのその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
MX9501608A (es) * 1994-04-01 1997-02-28 Lilly Co Eli 1h-indol-3-glioxilamidas inhibidoras de spla2.
JP2001520991A (ja) * 1997-10-27 2001-11-06 イーライ・リリー・アンド・カンパニー インドールｓＰＬＡ２阻害剤のＮ，Ｎ−ジエチルグリコールアミドエステルプロドラッグ
AU1200899A (en) * 1997-10-27 1999-05-17 Eli Lilly And Company Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors

Also Published As

Publication number Publication date
EP1220839B1 (de) 2006-12-06
JP2003509491A (ja) 2003-03-11
AU7053700A (en) 2001-04-24
DE60032254D1 (de) 2007-01-18
WO2001021587A3 (en) 2001-10-11
WO2001021587A2 (en) 2001-03-29
EP1220839A2 (de) 2002-07-10

Similar Documents

Publication Publication Date Title
ATE540923T1 (de) Ää3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- (phenylmethyl)-11h-indol-4-ylüoxyüessigsäure methyl ester als spla2 inhibitor
DE69724009D1 (de) PYRROLE ALS sPLA2 INHIBITOREN
ATE326963T1 (de) Indolverbindungen als spla2 inhibitoren
WO2002050030A3 (en) Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
ATE203744T1 (de) Naphthyl-acetamide als spla2-inhibitoren
DE69720034D1 (de) PHENYLGLYOXAMIDE ALS sPLA2-INHIBITOREN
ATE350367T1 (de) Spla2 inhibitoren
ATE312817T1 (de) Cyclohept'bö indolderivate als spla2-inhibitoren
ATE347545T1 (de) Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren
ATE353876T1 (de) Substituierte carbazole als inhibitoren von spla2
WO2002012249A3 (en) Substituted pyrrole compounds and their use as spla2 inhibitors
DE60126831D1 (de) Benz(g)indole und deren verwendung als spla2 inhibitoren
WO2002050028A8 (en) Substituted benzoindoles as spla2 inhibitors
WO2001049662A3 (en) Carbazole derivatives as inhibitors of spla2
DE60120758D1 (de) Tetracyclische derivate als spla2 inhibitoren
WO2002000641A3 (en) Spla2 inhibitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties